Cost effectiveness of combination HIV therapy: 3 years later (Q34007161)

30 July 2017

1 reference

title

Cost effectiveness of combination HIV therapy: 3 years later (English)

1 reference

cost-effectiveness analysis

30 July 2017

main subject

1 reference

Moore RD

1

1 reference

30 July 2017

publication date

1 April 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

17

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

325-330

1 reference

The economic costs of caring for people with HIV infection and AIDS in England and Wales

30 July 2017

cites work

1 reference

12 December 2020

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

12 December 2020

One world, one hope: the cost of providing antiretroviral therapy to all nations

1 reference

12 December 2020

Costs of HIV medical care in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Impact of combination therapy for HIV infection on inpatient census

1 reference

12 December 2020

Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS.

1 reference

12 December 2020

Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial

1 reference

12 December 2020

An evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing regimens in HIV infection. Canadian perspective

1 reference

12 December 2020

Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland

1 reference

12 December 2020

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

12 December 2020

Cost effectiveness of antiviral treatment with zalcitabine plus zidovudine for AIDS patients with CD4+ counts less than 300/microliters in 5 European countries

1 reference

12 December 2020

A prospective evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing antiretroviral treatment regimens in HIV infection. European perspective

1 reference

12 December 2020

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

12 December 2020

The cost-effectiveness of treatment with lamivudine and zidovudine compared with zidovudine alone: a comparison of Markov model and trial data estimates.

1 reference

12 December 2020

Modelling the potential economic impact of viral load-driven triple drug combination antiretroviral therapy.

1 reference

12 December 2020

Lifetime cost of human immunodeficiency virus-related health care

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Modelling the Cost Effectiveness of Lamivudine/Zidovudine Combination Therapy in HIV Infection

1 reference

12 December 2020

Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a Veterans Administration hospital

1 reference

12 December 2020

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA

1 reference

12 December 2020

The affordability of antiretroviral therapy in developing countries: what policymakers need to know

1 reference

12 December 2020

A prospective cost-consequence analysis of adding lamivudine to zidovudine-containing antiretroviral treatment regimens for HIV infection in the US.

1 reference

12 December 2020

Natural history of HIV infection in the era of combination antiretroviral therapy

1 reference

12 December 2020

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

1 reference

12 December 2020

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

12 December 2020

The lifetime cost of treating a person with HIV.

1 reference

12 December 2020

Combination antiretroviral therapy in HIV infection. An economic perspective

1 reference

12 December 2020

10.2165/00019053-200017040-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1004010849

0 references

1 reference